1 antithrombotic action for this inotropic and vasodilator drug.

2 t aggregation, and are a target for coronary vasodilator drugs.

3 mine whether the nonadrenergic inotropic and vasodilator drug amrinone, which elevates platelet cAMP

4 r administration of intravenous inotropic or vasodilator drugs for 4 hours or more without hospitaliz

5                        Also, cyclandelate, a vasodilator drug, has been synthesized in gram scale wit

6  Conventional therapy with anticoagulant and vasodilator drugs may improve symptoms and survival amon

7          Inhalation use of the new pulmonary vasodilator drugs represents a new frontier for intraope